Jacobs Levy Equity Management, Inc Rigel Pharmaceuticals Inc Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.12 - $1.57 $441,992 - $619,578	-394,636 Reduced 14.7%	2,289,587 $3.39 Million
Q4 2023 Feb 14, 2024	SELL	$0.72 - $1.56 $493,094 - $1.07 Million	-684,853 Reduced 20.33%	2,684,223 $3.89 Million
Q3 2023 Nov 16, 2023	SELL	$1.07 - $1.39 $216,230 - $280,898	-202,085 Reduced 5.66%	3,369,076 $3.64 Million
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $226,654 - $368,313	-202,370 Reduced 5.36%	3,571,161 $4.61 Million
Q1 2023 May 15, 2023	SELL	$1.25 - $2.0 $686,176 - $1.1 Million	-548,941 Reduced 12.7%	3,773,531 $4.98 Million
Q4 2022 Feb 14, 2023	BUY	$0.67 - $11.9 $912,855 - $16.2 Million	1,362,471 Added 46.03%	4,322,472 $6.48 Million
Q3 2022 Nov 15, 2022	BUY	$1.1 - $12.2 $3.26 Million - $36.1 Million	2,960,001 New	2,960,001 $3.49 Million
Q4 2020 Feb 16, 2021	SELL	$2.35 - $3.74 $104,295 - $165,984	-44,381 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.78 - $4.13 $2.42 Million - $5.62 Million	-1,361,601 Reduced 96.84%	44,381 $107,000
Q2 2020 Aug 17, 2020	BUY	$1.41 - $2.05 $827,952 - $1.2 Million	587,200 Added 71.72%	1,405,982 $2.57 Million
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $1.2 Million - $2.82 Million	-941,210 Reduced 53.48%	818,782 $1.28 Million
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $1.47 Million - $2.24 Million	921,371 Added 109.87%	1,759,992 $3.77 Million
Q3 2019 Nov 14, 2019	BUY	$1.63 - $2.62 $155,979 - $250,715	95,693 Added 12.88%	838,621 $1.57 Million
Q2 2019 Aug 13, 2019	BUY	$2.02 - $2.61 $189,678 - $245,079	93,900 Added 14.47%	742,928 $1.94 Million
Q1 2019 May 14, 2019	BUY	$2.0 - $2.65 $1.3 Million - $1.72 Million	649,028 New	649,028 $1.67 Million
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.59 $74,100 - $102,315	-28,500 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $80,655 - $117,135	28,500 New	28,500 $81,000
Q4 2017 Feb 13, 2018	SELL	$3.23 - $4.3 $1.16 Million - $1.55 Million	-359,449 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $607,890 - $716,641	278,849 Added 345.97%	359,449 $913,000
Q2 2017 Nov 09, 2017	BUY	N/A	80,600	80,600 $220,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account